Vaccines,
Journal Year:
2025,
Volume and Issue:
13(4), P. 415 - 415
Published: April 15, 2025
Human
Endogenous
Retroviruses
comprise
approximately
8%
of
the
human
genome,
serving
as
fragments
ancient
retroviral
infections.
Although
they
are
generally
maintained
in
a
silenced
state
by
robust
epigenetic
mechanisms,
specific
HERV
groups,
particularly
HERV-W
and
HERV-K,
can
become
derepressed
under
pathological
conditions,
thereby
contributing
to
initiation
progression
neuroinflammatory
neurodegenerative
processes.
Preclinical
studies
clinical
trials,
such
those
investigating
monoclonal
antibodies,
indicate
that
directly
targeting
these
elements
may
offer
novel
therapeutic
strategy.
In
this
review,
we
provide
an
overview
HERVs′
biology,
examine
their
role
diseases
amyotrophic
lateral
sclerosis,
multiple
Alzheimer′s
disease,
Parkinson′s
explore
prospects,
highlighting
both
challenges
potential
future
research
directions
needed
translate
approaches
into
interventions.
Genes,
Journal Year:
2025,
Volume and Issue:
16(1), P. 93 - 93
Published: Jan. 17, 2025
Male
reproductive
health
is
governed
by
an
intricate
interplay
of
genetic,
epigenetic,
and
environmental
factors.
Epigenetic
mechanisms—encompassing
DNA
methylation,
histone
modifications,
non-coding
RNA
activity—are
crucial
both
for
spermatogenesis
sperm
maturation.
However,
oxidative
stress,
driven
excessive
reactive
oxygen
species,
disrupts
these
processes,
leading
to
impaired
function
male
infertility.
This
disruption
extends
epigenetic
resulting
in
abnormal
gene
expression
chromatin
remodeling
that
compromise
genomic
integrity
fertilization
potential.
Importantly,
oxidative-stress-induced
alterations
can
be
inherited,
affecting
the
fertility
offspring
future
generations.
review
investigates
how
stress
influences
regulation
reproduction
modifying
RNAs,
ultimately
compromising
spermatogenesis.
Additionally,
it
discusses
transgenerational
implications
disruptions
their
potential
role
hereditary
infertility
disease
predisposition.
Understanding
mechanisms
vital
developing
therapeutic
strategies
mitigate
damage
restore
homeostasis
germline.
By
integrating
insights
from
molecular,
clinical,
research,
this
work
emphasizes
need
targeted
interventions
enhance
prevent
adverse
outcomes
progeny.
Furthermore,
elucidating
dose–response
relationships
between
changes
remains
a
critical
research
priority,
informing
personalized
diagnostics
interventions.
In
context,
studies
should
adopt
standardized
markers
damage,
robust
clinical
trials,
multi-omic
approaches
capture
complexity
Such
rigorous
investigations
will
reduce
risk
disorders
optimize
outcomes.
Autoimmunity Reviews,
Journal Year:
2025,
Volume and Issue:
24(6), P. 103784 - 103784
Published: March 3, 2025
Autoimmune
diseases
result
from
complex
interactions
between
genetic
and
environmental
factors.
Recent
advances
in
epigenetic
research
shed
light
on
the
intricate
regulatory
mechanisms
that
contribute
to
development
progression
of
such
conditions.
The
present
review
aims
explore
role
modifications,
including
DNA
methylation,
histone
non-coding
RNAs,
context
autoimmune
diseases.
We
discuss
current
understanding
alterations
associated
with
various
disorders,
their
impact
immune
cell
function,
potential
as
innovative
therapeutic
targets.
Additionally,
we
highlight
main
future
directions
field
epigenetics
autoimmunity.
Molecular Cancer,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: March 8, 2025
Epigenomic
modifications—such
as
DNA
methylation,
histone
acetylation,
and
methylation—and
their
implications
in
tumorigenesis,
progression,
treatment
have
emerged
a
pivotal
field
cancer
research.
Tumors
undergo
metabolic
reprogramming
to
sustain
proliferation
metastasis
nutrient-deficient
conditions,
while
suppressing
anti-tumor
immunity
the
tumor
microenvironment
(TME).
Concurrently,
immune
cells
within
immunosuppressive
TME
adaptations,
leading
alterations
function.
The
complicated
interplay
between
metabolites
epigenomic
modulation
has
spotlighted
significance
of
regulation
immunometabolism.
In
this
review,
characteristics
modification
associated
with
tumors
are
systematically
summarized
alongside
regulatory
roles
Classical
emerging
approaches
delineated
broaden
boundaries
research
on
crosstalk
immunometabolism
epigenomics.
Furthermore,
we
discuss
potential
therapeutic
strategies
that
target
modulate
modifications,
highlighting
burgeoning
synergy
therapies
immunotherapy
promising
avenue
for
treatment.
Biomolecules,
Journal Year:
2025,
Volume and Issue:
15(1), P. 71 - 71
Published: Jan. 6, 2025
The
tumor
microenvironment
(TME)
plays
a
pivotal
role
in
neoplastic
initiation
and
progression.
Epigenetic
machinery,
governing
the
expression
of
core
oncogenes
suppressor
genes
transformed
cells,
significantly
contributes
to
development
at
both
primary
distant
sites.
Recent
studies
have
illuminated
how
epigenetic
mechanisms
integrate
external
cues
downstream
signals,
altering
phenotype
stromal
cells
immune
cells.
This
remolds
area
surrounding
ultimately
fostering
an
immunosuppressive
microenvironment.
Therefore,
correcting
TME
by
targeting
modifications
holds
substantial
promise
for
cancer
treatment.
review
synthesizes
recent
research
that
elucidates
impact
specific
regulations-ranging
from
DNA
methylation
histone
chromatin
remodeling-on
within
TME.
Notably,
we
highlight
their
functional
roles
either
promoting
or
restricting
We
also
discuss
potential
applications
agents
treatment,
envisaging
ability
normalize
ecosystem.
aims
assist
researchers
understanding
dynamic
interplay
between
epigenetics
TME,
paving
way
better
therapy.
International Journal of Biological Sciences,
Journal Year:
2025,
Volume and Issue:
21(3), P. 958 - 973
Published: Jan. 6, 2025
Viral
mimicry
refers
to
an
active
antiviral
response
triggered
by
the
activation
of
endogenous
retroviruses
(ERVs),
usually
manifested
formation
double-stranded
RNA
(dsRNA)
and
cellular
interferon
response,
which
activates
immune
system
produces
anti-tumor
effects.
Epigenetic
studies
have
shown
that
epigenetic
modifications
(e.g.
DNA
methylation,
histone
modifications,
etc.)
play
a
crucial
role
in
tumorigenesis,
progression,
treatment
resistance.
Particularly,
alterations
methylation
may
be
closely
associated
with
suppression
ERVs
expression,
demethylation
restore
activity
thus
strengthen
tumor
response.
Therefore,
we
propose
viral
can
induce
responses
microenvironment
activating
expression
ERVs,
key
regulatory
this
process.
In
paper,
review
intersection
mimicry,
epigenetics
immunotherapy,
explore
possible
interactions
synergistic
effects
among
three,
aiming
provide
new
theoretical
basis
potential
strategies
for
cancer
immunotherapy.
Epigenomes,
Journal Year:
2025,
Volume and Issue:
9(1), P. 5 - 5
Published: Feb. 5, 2025
Genomic
and
epigenomic
instability
are
defining
features
of
cancer,
driving
tumor
progression,
heterogeneity,
therapeutic
resistance.
Central
to
this
process
epigenetic
echoes,
persistent
dynamic
modifications
in
DNA
methylation,
histone
modifications,
non-coding
RNA
regulation,
chromatin
remodeling
that
mirror
underlying
genomic
chaos
actively
influence
cancer
cell
behavior.
This
review
delves
into
the
complex
relationship
between
these
illustrating
how
they
collectively
shape
genome,
affect
repair
mechanisms,
contribute
evolution.
However,
dynamic,
context-dependent
nature
changes
presents
scientific
ethical
challenges,
particularly
concerning
privacy
clinical
applicability.
Focusing
on
lung
we
examine
specific
patterns
function
as
biomarkers
for
distinguishing
subtypes
monitoring
disease
progression
relapse.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 8, 2025
ABSTRACT
Intrabodies
are
engineered
antibodies
that
function
inside
living
cells,
enabling
therapeutic,
diagnostic,
and
imaging
applications.
While
powerful,
their
development
has
been
hindered
by
challenges
associated
with
folding,
solubility,
stability
in
the
reduced
intracellular
environment.
Here,
we
present
an
AI-driven
pipeline
integrating
AlphaFold2,
ProteinMPNN,
live-cell
screening
to
optimize
antibody
framework
regions
while
preserving
epitope-binding
complementarity-determining
regions.
Using
this
approach,
successfully
converted
19
out
of
26
sequences
into
functional
single-chain
variable
fragment
(scFv)
intrabodies,
including
a
panel
targeting
diverse
histone
modifications
for
real-time
chromatin
dynamics
gene
regulation.
Notably,
18
these
had
failed
convert
using
standard
demonstrating
unique
effectiveness
our
method.
As
sequence
databases
expand,
method
will
accelerate
intrabody
design,
making
easier,
more
cost-effective,
broadly
accessible
biological
research.
Epigenomes,
Journal Year:
2025,
Volume and Issue:
9(1), P. 6 - 6
Published: Feb. 11, 2025
Aberrant
hypermethylation
in
the
promoter
regions
of
tumor
suppressor
genes
facilitates
pathogenesis
and
progression
cancer.
Therefore,
inhibitors
targeting
DNA
methyltransferase
(DNMT)
have
been
tested
clinical
studies.
However,
current
monotherapy
DNMT
shows
limited
efficacy.
Furthermore,
mechanism
action
is
replication-dependent.
To
address
these
limitations,
we
developed
a
novel
core-shell-type
"epigenetics
control
(EpC)
nanocarrier"
that
encapsulated
decitabine
(5-aza-dC)
PLGA
core
nanoparticle
hybridized
TET1
gene-encoding
pDNA
on
lipid
shell
surface.
This
study
aimed
to
evaluate
whether
dual
delivery
could
synergistically
enhance
gene
expression
induce
cell
cycle
arrest
and/or
apoptosis
cancer
cells.
Herein,
demonstrate
potential
EpC
carrier
HCT116
human
colon
cells
upregulate
rapidly
achieve
arrest.
nanoparticles
were
prepared
by
W/O/W
double
emulsion
method.
The
formation
core-shell
complexation
with
investigated
optimized
dynamic
light
scattering,
zeta
measurement,
agarose
gel
electrophoresis.
cellular
uptake
transfection
efficiency
measured
confocal
laser
scanning
microscopy
luciferase
assay,
respectively.
p53
protein
was
detected
Western
blotting.
anti-tumor
effects
nanocarrier
evaluated
analysis
an
assay.
delivered
inhibitor
TET
into
It
promoted
induced
rapid
G2/M
phase
Our
findings
suggest
dual-targeting
enzymes
effectively
repairs
aberrant
methylation
induces
growth
cells,
strategy
may
contribute
advancement
epigenetic
therapy.